Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-218,115
Closed -$4.82M 632
2022
Q2
$4.82M Buy
218,115
+77,837
+55% +$1.98M 0.02% 259
2022
Q1
$3.45M Sell
140,278
-109,722
-44% -$3.07M 0.01% 316
2021
Q4
$8.28M Buy
250,000
+45,000
+22% +$1.43M 0.03% 149
2021
Q3
$5.98M Sell
205,000
-656,800
-76% -$19.7M 0.02% 192
2021
Q2
$26.3M Buy
861,800
+611,800
+245% +$19.4M 0.12% 89
2021
Q1
$7.39M Buy
250,000
+12,500
+5% +$358K 0.04% 137
2020
Q4
$6.78M Sell
237,500
-583,061
-71% -$15.9M 0.03% 125
2020
Q3
$18.2M Buy
820,561
+399,707
+95% +$9.26M 0.1% 83
2020
Q2
$9.49M Buy
+420,854
New +$8.61M 0.05% 104

Other funds holding AXTA

Brookfield Corp's AXTA Position: Q3 2022 in Review

Brookfield Corp sold out of Axalta (AXTA) in Q3 2022, closing a stake of 218,115 shares — an estimated $4.82M sold.

Brookfield Corp first reported a position in AXTA in Q2 2020 and held it in 9 quarters. The position peaked at $26.3M in Q2 2021. 279 funds tracked by Wall St. Rank hold AXTA as of Q3 2022.

  • Brookfield Corp reported no remaining Axalta position as of Q3 2022 after selling out during the quarter.
  • Brookfield Corp sold 218,115 Axalta shares in Q3 2022, an estimated $4.82M.
  • Brookfield Corp first reported a position in Axalta in Q2 2020 and held it in 9 quarters.
  • Brookfield Corp's Axalta position peaked at $26.3M in Q2 2021.
  • 279 funds tracked by Wall St. Rank held Axalta as of Q3 2022.

Based on Brookfield Corp's 13F filing for Q3 2022, filed 14 Nov 2022.